PMC:7275193 / 6181-6777
Annnotations
LitCovid-PMC-OGER-BB
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T87 | 74-82 | SP_7 | denotes | COVID-19 |
| T88 | 176-185 | CHEBI:45409;DG_30;CHEBI:45409 | denotes | ritonavir |
| T89 | 191-200 | CHEBI:31781;DG_23;CHEBI:31781 | denotes | lopinavir |
| T90 | 234-245 | DG_35 | denotes | tocilizumab |
| T91 | 275-293 | DG_36 | denotes | methylprednisolone |
| T92 | 477-481 | UBERON:0001456 | denotes | face |
| T69104 | 74-82 | SP_7 | denotes | COVID-19 |
| T95417 | 176-185 | CHEBI:45409;DG_30;CHEBI:45409 | denotes | ritonavir |
| T91340 | 191-200 | CHEBI:31781;DG_23;CHEBI:31781 | denotes | lopinavir |
| T62090 | 234-245 | DG_35 | denotes | tocilizumab |
| T45712 | 275-293 | DG_36 | denotes | methylprednisolone |
| T7248 | 477-481 | UBERON:0001456 | denotes | face |
LitCovid-PD-FMA-UBERON
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T25 | 138-146 | Body_part | denotes | cytokine | http://purl.org/sig/ont/fma/fma84050 |
| T26 | 460-464 | Body_part | denotes | back | http://purl.org/sig/ont/fma/fma25056 |
| T27 | 477-481 | Body_part | denotes | face | http://purl.org/sig/ont/fma/fma24728 |
LitCovid-PD-UBERON
| Id | Subject | Object | Predicate | Lexical cue | uberon_id |
|---|---|---|---|---|---|
| T30 | 477-481 | Body_part | denotes | face | http://purl.obolibrary.org/obo/UBERON_0001456 |
LitCovid-PD-HP
| Id | Subject | Object | Predicate | Lexical cue | hp_id |
|---|---|---|---|---|---|
| T38 | 83-92 | Phenotype | denotes | pneumonia | http://purl.obolibrary.org/obo/HP_0002090 |
| T39 | 138-152 | Phenotype | denotes | cytokine storm | http://purl.obolibrary.org/obo/HP_0033041 |
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T71 | 4-22 | Disease | denotes | infectious disease | http://purl.obolibrary.org/obo/MONDO_0005550 |
| T72 | 74-82 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T73 | 83-92 | Disease | denotes | pneumonia | http://purl.obolibrary.org/obo/MONDO_0005249 |
| T74 | 108-112 | Disease | denotes | ARDS | http://purl.obolibrary.org/obo/MONDO_0006502 |
| T75 | 401-403 | Disease | denotes | he | http://purl.obolibrary.org/obo/MONDO_0017319 |
| T76 | 445-447 | Disease | denotes | he | http://purl.obolibrary.org/obo/MONDO_0017319 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T86 | 57-58 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T87 | 136-137 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T88 | 338-341 | http://purl.obolibrary.org/obo/CLO_0051582 | denotes | has |
| T89 | 388-389 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T90 | 468-469 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T91 | 477-481 | http://purl.obolibrary.org/obo/UBERON_0001456 | denotes | face |
| T92 | 523-526 | http://purl.obolibrary.org/obo/CLO_0051582 | denotes | has |
| T93 | 580-583 | http://purl.obolibrary.org/obo/CLO_0008477 | denotes | pO2 |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T40 | 176-185 | Chemical | denotes | ritonavir | http://purl.obolibrary.org/obo/CHEBI_45409 |
| T41 | 191-200 | Chemical | denotes | lopinavir | http://purl.obolibrary.org/obo/CHEBI_31781 |
| T42 | 234-245 | Chemical | denotes | tocilizumab | http://purl.obolibrary.org/obo/CHEBI_64360 |
| T43 | 275-293 | Chemical | denotes | methylprednisolone | http://purl.obolibrary.org/obo/CHEBI_6888 |
| T44 | 516-522 | Chemical | denotes | oxygen | http://purl.obolibrary.org/obo/CHEBI_25805 |
| T45 | 592-594 | Chemical | denotes | Hg | http://purl.obolibrary.org/obo/CHEBI_16170|http://purl.obolibrary.org/obo/CHEBI_25195 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T57 | 0-153 | Sentence | denotes | The infectious disease team recommended to manage him as a case of severe COVID-19 pneumonia complicated by ARDS, which might be due to a cytokine storm. |
| T58 | 154-381 | Sentence | denotes | Therefore, they added ritonavir plus lopinavir 500 mg orally daily for 14 days, tocilizumab 400 mg i.v. single dose, and methylprednisolone 40 mg i.v. every 12 h for 5 days, and BiPAP has been applied to improve his SpO2 level. |
| T59 | 382-537 | Sentence | denotes | After a few hours, he started to improve with this regimen, so he was shifted back to a simple face mask, and gradually the amount of oxygen has decreased. |
| T60 | 538-596 | Sentence | denotes | The repeated ABG showed an improvement in pO2 (100 mm Hg). |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 187 | 176-185 | Chemical | denotes | ritonavir | MESH:D019438 |
| 188 | 191-200 | Chemical | denotes | lopinavir | MESH:D061466 |
| 189 | 234-245 | Chemical | denotes | tocilizumab | MESH:C502936 |
| 190 | 275-293 | Chemical | denotes | methylprednisolone | MESH:D008775 |
| 191 | 516-522 | Chemical | denotes | oxygen | MESH:D010100 |
| 192 | 580-583 | Chemical | denotes | pO2 | MESH:C093415 |
| 193 | 4-22 | Disease | denotes | infectious disease | MESH:D003141 |
| 194 | 74-92 | Disease | denotes | COVID-19 pneumonia | MESH:C000657245 |
| 195 | 108-112 | Disease | denotes | ARDS | MESH:D012128 |